enGene Therapeutics (ENGN) Net Income (2023 - 2026)
enGene Therapeutics (ENGN) posted Net Income of -$32.5 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$28.99 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Net Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Net Income at enGene Therapeutics was -$130.36 million; for FY2025 (ended Oct 31, 2025), it was -$117.3 million.
- In prior fiscal years, enGene Therapeutics' Net Income was -$55.14 million in FY2024, -$99.92 million in FY2023 and -$24.46 million in FY2022.
- Quarterly Net Income has run from a low of -$82.5 million in fiscal Q4 2023 to a high of -$4.72 million in fiscal Q3 2023 over five years.
- According to Business Quant data, Net Income for the three prior fiscal quarters was -$30.23 million (Q2 2026), -$29.75 million (Q1 2026) and -$37.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | -248.00 Mn |
| 10 | enGene Therapeutics | 109.83 Mn | -884.64 Mn | - | -32.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -32.50 Mn |
| Apr 30, 2026 | -30.23 Mn |
| Jan 31, 2026 | -29.75 Mn |
| Oct 31, 2025 | -37.88 Mn |
| Jul 31, 2025 | -28.99 Mn |
| Apr 30, 2025 | -25.82 Mn |
| Jan 31, 2025 | -24.62 Mn |
| Oct 31, 2024 | -15.30 Mn |
| Jul 31, 2024 | -14.15 Mn |
| Apr 30, 2024 | -14.98 Mn |
| Jan 31, 2024 | -10.71 Mn |
| Oct 31, 2023 | -82.50 Mn |
| Jul 31, 2023 | -4.72 Mn |
| Apr 30, 2023 | -5.28 Mn |
| Jan 31, 2023 | -7.42 Mn |
API Access
enGene Therapeutics Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();